The incidence and survival of acute de novo leukaemias in Estonia and in a well defined region of Western Sweden during 1982-1996: A survey of patients aged 16-64 years

Leukemia and Lymphoma

Volumn 45, Issue 5, 2004, Pages 915-921

  Wennström, Lovisa ^a   Juntikka, Eva Lena ^a   Safai Kutti, Soodabeh ^a   Stockelberg, Dick ^a   Holmberg, Erik ^a   Luik, Ene ^b   Everaus, Hele ^b   Palk, Katrin ^c   Varik, Mirja ^c   Aareleid, Tiiu ^d   Kutti, Jack ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b TARTU UNIVERSITY CLINICS   (Estonia)

^c East Tallinn Central Hospital   (Estonia)

^d Estonian Cancer Registry   (Estonia)

Author keywords

Acute de novo leukaemia; Estonia; Incidence; Survival; Sweden

Indexed keywords

ANTHRACYCLINE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; ASPARAGINASE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; VINCRISTINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CONTROLLED STUDY; ECONOMIC ASPECT; ENVIRONMENTAL FACTOR; ESTONIA; FEMALE; GEOGRAPHY; HEALTH SURVEY; HUMAN; LEUKEMIA; MALE; POLITICS; POPULATION BIOLOGY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOCIAL ASPECT; STATISTICAL SIGNIFICANCE; SWEDEN;

ACUTE DISEASE; ADOLESCENT; ADULT; DELIVERY OF HEALTH CARE; ESTONIA; FEMALE; HUMANS; INCIDENCE; LEUKEMIA; MALE; MIDDLE AGED; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; SWEDEN;

EID: 11144357111     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001623865     Document Type: Article

References (27)

1. The World Bank (1993) The development report 1993: Investing in health. New York: Oxford University Press.
2. The World Bank (1993) Estonia: The transition to a market economy. A World Bank country study. Washington: The World Bank.
3. Pierce, N. (1993) "WAste management challenges in Russia, Ukraine, and Estonia", Waste Age, 24, 194-202.
4. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R., et al. (1985) "PRoposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group", Ann. Intern. Med., 103, 620-625.
5. Cheson, B.D., Cassileth, P.A., Head, D.R., Schiffer, C.A., Bennett, J.M., Bloomfield, C.D., et al. (1990) "REport of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia", J. Clin. Oncol., 8, 813-819.
6. Öst, Å. and Reizenstein, P. (1992) "MInimal diagnostic criteria for the myelodysplastic syndrome", Leuk. Res., 16, 9-11.
7. Rothmann, K.J. (1986) Modern Epidemiology. Boston: Little, Brown and Company.
8. Hakulinen, T. and Abeywickrama, K.H. (1985) "A computer program package for relative survival analysis", Comput. Programs Biomed., 19, 197-207.
9. Hakulinen, T., Tenkanen, L., Abeywickrama, K. and Päivärinta, L. (1987) "TEsting equality of relative survival patterns based on aggregated data", Biometrics, 43, 313-325.
10. Shore, D.L., Sandler, D.P., Davey, F.R., McIntyre, O.R. and Bloomfield, C.D. (1993) "ACute leukemia and residential proximity to potential sources of environmental pollutants", Arch. Environ. Health, 48, 414-420.
11. Linos, A., Blair, A., Gibson, R.W., Everett, G., Van Lier, S., Cantor, K.P., et al. (1991) "LEukemia and non-Hodgkin's lymphoma and residential proximity to industrial plants", Arch. Environ. Health, 46, 70-74.
12. Åström, M., Bodin, L. and Tidefelt, U. (2001) "ADjustment of incidence rates after an estimate of completeness and accuracy in registration of acute leukemias in a Swedish population", Leuk. Lymphoma, 41, 559-570.
13. Öst, Å., Lindström, P., Christensson, B., Gyllenhammar, H. and Engsted, L. (1984) "ACute leukaemia in a defined geographic area -Incidence, clinical history and prognosis", Scand. J. Haematol., 33, 160-170.
14. Lamvik, J., Dybedal, I., Hammerstrom, J. and Waage, A. (1994) "ACute leukemia in middle Norway 1984-88", Leuk. Lymphoma, 16, 65-71.
15. Carli, P.M., Milan, C., Lange, A., Devilliers, E., Guy, H. and Faivre, J. (1986) "HAematopoietic malignancies in Cote d'Or (France): A population based study", Br. J. Cancer, 53, 811-815.
16. McKinney, P.A., Alexander, F.E., Cartwright, R.A. and Ricketts, T.J. (1989) "THe leukaemia research fund data collection survey: The incidence and geographical distribution of acute myeloid leukemia", Leukemia, 3, 875-879.
17. Bowie, C. (1987) "THe validity of a cancer register in leukaemia epidemiology", Community Med., 9, 152-159.
18. Mattsson, B., Rutqvist, L.E. and Wallgren, A. (1985) "UNder-notification of diagnosed cancer cases to the Stockholm Cancer Registry", Int. J. Epidemiol., 14, 64-69.
19. Lang, K., Mägi, M., Tikk, M. and Aareleid, T. (2001) "EEsti Vähiregistri andmete täielikkuse uuring", Eesti Arst, 80, 320-324.
20. Bishop, J.F., Matthews, J.P., Young, G.A., Szer, J., Gillett, A., Joshua, D., et al. (1996) "A randomized study of high-dose cytarabine in induction in acute myeloid leukemia", Blood, 87, 1710-1717.
21. Harousseau, J.L., Cahn, J.Y., Pignon, B., Witz, F., Milpied, N., Delain, M., et al. (1997) "COmparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia", Blood, 90, 2978-2986.
22. Weick, J.K., Kopecky, K.J., Appelbaum, F.R., Head, D.R., Kingsbury, L.L., Balcerzak, S.P., et al. (1996) "A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: A Southwest Oncology Group study", Blood, 88, 2841-2851.
23. Byrd, J.C., Mrózek, K., Dodge, R.K., Carroll, A.J., Edwards, C.G., Arthur, D.C., et al. (2002) "PRetreatment cytogenctic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B (CALGB 8461)", Blood, 100, 4325-4336.
24. Hallböök, H., Simonsson, B., Ahlgren, T., Björkholm, M., Carneskog, J., Grimfors, G., et al. (2002) "HIgh-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia", Br. J. Haematol., 118, 748-754.
25. Xie, Y., Davies, S.M., Xiang, Y., Robison, L.L. and Ross, J.A. (2003) "TRends in leukemia incidence and survival in the United States", (1973-1998) Cancer, 97, 2229-2235.
26. Tsimberidou, A.-M., Stavroyianni, N., Viniou, N., Papaioannou, M., Tiniakou, M., Marinakis, T., et al. (2003) "COmparison of allogencic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia", Cancer, 97, 1721-1731.
27. Nilsson, B., Gustavson-Kadaka, E., Hakulinen, T., Aareleid, T., Rahu, M., Dyba, T., et al. (1997) "CAncer survival in Estonian migrants to Sweden", J. Epidemiol. Community Health, 51, 418-423.